Program Update!

Effective January 1st, Genentech will be updating the co-pay program benefit period. The program will be moving from a 12-month benefit to a calendar year benefit (January to December).

Patient benefit will automatically renew annually for all patients enrolled in the program on January 1st.

For more information, please call the Help Desk at 800-636-0316.

The information contained in this section of the site is intended for US specialty pharmacy representatives only. Click "OK" if you are a specialty pharmacy representative.

Indication and Important Safety Information  |  Prescribing Information

You pay as little as $5 per prescription for Evrysdi if you qualify for the Evrysdi Co-pay Program. Eligible commercially insured patients who are prescribed Evrysdi for an FDA-approved use can receive up to $25,000 per calendar year for drug costs.

Apply Now

Have a temporary reference number and want to return to the confirmation screen?

Enter your information here:

Indication and Important Safety Information

What is Evrysdi?

Evrysdi is a prescription medicine used to treat spinal muscular atrophy (SMA) in children and adults.

Important Safety Information

  • Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
    • are pregnant or plan to become pregnant, as Evrysdi may harm your unborn baby. Ask your healthcare provider for advice before taking this medicine
    • are a woman who can become pregnant:
      • Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy
      • Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
      • Pregnancy Registry. Talk to your healthcare provider right away if you become pregnant while taking Evrysdi. Ask about registering with the Evrysdi Pregnancy Registry, which was created to collect information about your health and your baby's health. Your healthcare provider can enroll you in this registry by calling 1-833-760-1098 or visiting https://www.evrysdipregnancyregistry.com.
    • are an adult male. Evrysdi may affect a man's ability to have children (fertility). Ask a healthcare provider for advice before taking this medicine
    • are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby
  • Tell your healthcare provider about all the medicines you take
  • You should receive Evrysdi from the pharmacy as a liquid. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
  • Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
  • The most common side effects of Evrysdi include:
    • For later-onset SMA:
      • fever
      • diarrhea
      • rash
    • For infantile-onset SMA:
      • fever
      • diarrhea
      • rash
      • runny nose, sneezing and sore throat (upper respiratory infection)
      • lung infection (lower respiratory infection)
      • constipation
      • vomiting
      • cough

These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see accompanying full Prescribing Information for additional Important Safety Information.

close

We are open from 9 a.m. to 8 p.m. ET, Monday through Friday, except for the following holidays:

  • New Year's Day
  • Martin Luther King Jr. Day
  • Memorial Day
  • Independence Day
  • Labor Day
  • Thanksgiving Holiday (Thursday and Friday)
  • Christmas Holiday

Questions about this program?

Call (833) EVRYSDI (833-387-9734)
9 a.m.–8 p.m. ET, Monday through Friday (except major holidays)
 
For questions about Evrysdi, please call (833) EVRYSDI (833-387-9734).

 
© 2023 Genentech USA, Inc.    So. San Francisco, CA
All rights reserved.

Fax (866) 796-1448

Privacy Policy |  Cookie Preferences